НовостиBenzingaStifel Initiates Coverage On City Therapeutics with Buy Rating, Announces Price Target of $34 Stifel Initiates Coverage On City Therapeutics with Buy Rating, Announces Price Target of $34 Benzinga 2026.11.10 10:11 (GMT+0) Открыть на Benzinga Другие новости